Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTE

PolarityTE (PTE) Stock Price, News & Analysis

PolarityTE logo

About PolarityTE Stock (NASDAQ:PTE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$0.57
52-Week Range
N/A
Volume
8.50 million shs
Average Volume
249,591 shs
Market Capitalization
$1.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolarityTE and its competitors with MarketBeat's FREE daily newsletter.

PTE Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Regenetp Inc RGTPQ
RegenETP, Inc. (NJT.SG)
PolarityTE Stock (NASDAQ:PTE), Dividends
See More Headlines

PTE Stock Analysis - Frequently Asked Questions

PolarityTE, Inc. (NASDAQ:PTE) announced its quarterly earnings results on Wednesday, November, 10th. The company reported ($2.25) earnings per share for the quarter, topping analysts' consensus estimates of ($3.00) by $0.75. The company had revenue of $1.12 million for the quarter, compared to analyst estimates of $0.97 million.

PolarityTE's stock reverse split before market open on Tuesday, May 17th 2022.The 1-25 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that PolarityTE investors own include Bionano Genomics (BNGO), Acasti Pharma (ACST), T2 Biosystems (TTOO), SNDL (SNDL), Zomedica (ZOM), Tonix Pharmaceuticals (TNXP) and Vaxart (VXRT).

Company Calendar

Last Earnings
11/10/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PTE
CIK
1076682
Employees
42
Year Founded
1986

Profitability

EPS (Trailing Twelve Months)
($3.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.83 million
Net Margins
N/A
Pretax Margin
-11,376.71%
Return on Equity
-106.08%
Return on Assets
-76.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.11
Quick Ratio
4.11

Sales & Book Value

Annual Sales
$810 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.30 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,380,000
Free Float
6,978,000
Market Cap
$1.78 million
Optionable
Optionable
Beta
1.15

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:PTE) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners